High levels of EREG expression in colorectal cancer (CRC) associate with better therapeutic outcomes, while EREG overexpression in non-small cell lung cancer may be a therapeutic target for EGFR-TKI (Lin et al. 2020). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.